1
|
Epidemiological time-trend of amyotrophic lateral sclerosis (ALS) over two decades: The French population-based register of ALS in Limousin (FRALim register). Rev Neurol (Paris) 2022; 178:914-923. [PMID: 36163089 DOI: 10.1016/j.neurol.2022.05.004] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/08/2022] [Revised: 05/25/2022] [Accepted: 05/31/2022] [Indexed: 11/20/2022]
Abstract
INTRODUCTION Population-based registers are key to understanding disease patterns. Taking advantage of the long-standing operation of the French register of amyotrophic lateral sclerosis (ALS) in Limousin (FRALim register), we sought to determine the time trends in incidence, clinical features and survival of ALS patients from 2000 to 2020. METHODS FRALim register included incident cases through multiple sources of ascertainment. A capture-recapture method was used to assess the exhaustiveness of case ascertainment. Crude and standardized incidences were calculated per 100,000 person-years of follow-up (PYFU). Time-period was divided (period 2000 to 2010 and period 2011 to 2020) to compare incidence rates and clinical features. Survival was analyzed using Kaplan-Meier method. Cox proportional hazards model was performed to calculate hazards for the time periods. RESULTS Overall, 501 incident cases were identified during 21 years. The overall crude incidence was 3.26 (95% CI 2.97 to 3.55) per 100 000 PYFU. The exhaustiveness of the register was estimated at 98.8% (95% CI 97.4-99.6%) by capture-recapture analysis. Several fluctuations were observed without a consistent trend over the last two decades. The crude and standardized incidences were higher in males than females. The peak of incidence was observed in the 75-79 years age band. Almost one-third of the cases exhibited a bulbar onset. There were significant differences in clinical features between time periods. Four hundred and ninety-one cases were included in the survival analysis. The median survival time from diagnosis was 16.0 months (95% CI 14.3 to 17.7 months). Patients in the last decade experienced a lower risk of dying but the difference did not reach statistical significance (adjusted HR: 0.89 (95% CI 0.73 to 1.08, P=0.229). CONCLUSION We provided reliable epidemiological data over two decades. We showed that incidence has been relatively stable, while clinical variability was observed. A slight improvement in survival time was found in the last decade but it was not statistically significant. Further quality register data are needed to improve our understanding of ALS epidemiological trends.
Collapse
|
2
|
Brown CA, Lally C, Kupelian V, Flanders WD. Estimated Prevalence and Incidence of Amyotrophic Lateral Sclerosis and SOD1 and C9orf72 Genetic Variants. Neuroepidemiology 2021; 55:342-353. [PMID: 34247168 DOI: 10.1159/000516752] [Citation(s) in RCA: 64] [Impact Index Per Article: 21.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/16/2020] [Accepted: 04/20/2021] [Indexed: 11/19/2022] Open
Abstract
INTRODUCTION Amyotrophic lateral sclerosis (ALS) is a rare neurological disorder characterized by progressive deterioration of motor neurons. Assessment of the size/geographic distribution of the ALS population, including ALS with genetic origin, is needed to understand the burden of the disease and the need for clinical intervention and therapy. OBJECTIVES The main objective of this study was to estimate the number of prevalent and incident ALS cases overall and superoxide dismutase 1 (SOD1) and chromosome 9 open reading frame 72 (C9orf72) ALS in 22 countries across Europe (Belgium, France, Germany, Ireland, Italy, Netherlands, Norway, Russia, Spain, Sweden, and UK), North America (USA and Canada), Latin America (Argentina, Brazil, Colombia, Mexico, and Uruguay), and Asia (China, Japan, South Korea, and Taiwan). METHODS A comprehensive literature search was conducted to identify population-based studies reporting ALS prevalence and/or incidence rates. Pooled prevalence and incidence rates were obtained using a meta-analysis approach at the country and regional geographic level. A country-level pooled estimate was used when ≥2 studies were available per country and geographic regional pooled estimates were used otherwise. The proportion of cases with a SOD1 or C9orf72 mutation among sporadic (sALS) and familial (fALS) cases were obtained from a previous systematic review and meta-analysis. RESULTS Pooled prevalence rates (per 100,000 persons) and incidence rates (per 100,000 person-years) were 6.22 and 2.31 for Europe, 5.20 and 2.35 for North America, 3.41 and 1.25 for Latin America, 3.01 and 0.93 for Asian countries excluding Japan, and 7.96 and 1.76 for Japan, respectively. Significant heterogeneity in reported incidence and prevalence was observed within and between countries/geographic regions. The estimated number of 2020 ALS cases across the 22 countries is 121,028 prevalent and 41,128 incident cases. The total estimated number of prevalent SOD1 cases is 2,876 cases, of which, 1,342 (47%) were fALS and 1,534 (53%) were sALS, and the number of incident SOD1 cases is 946 (434 [46%] fALS and 512 [54%] sALS). The total estimated number of prevalent C9orf72 cases is 4,545 (1,198 [26%] fALS, 3,347 [74%] sALS), and the number of incident C9orf72 cases is 1,706 (450 [26%] fALS and 1,256 [74%] sALS). DISCUSSION The estimated number of patients with SOD1 and C9orf72 ALS suggests that although the proportions of SOD1 and C9orf72 are higher among those with fALS, the majority of SOD1 and C9orf72 ALS cases may be found among those with sALS (about 53 and 74%, respectively). These results suggest that classification of fALS based on reported family history does not capture the full picture of ALS of genetic origin.
Collapse
Affiliation(s)
- Carolyn A Brown
- Epidemiologic Research and Methods LLC, Atlanta, Georgia, USA.,Department of Epidemiology, Rollins School of Public Health, Atlanta, Georgia, USA
| | - Cathy Lally
- Epidemiologic Research and Methods LLC, Atlanta, Georgia, USA
| | | | - W Dana Flanders
- Epidemiologic Research and Methods LLC, Atlanta, Georgia, USA.,Department of Epidemiology, Rollins School of Public Health, Atlanta, Georgia, USA
| |
Collapse
|
3
|
Chiò A, Mora G, Moglia C, Manera U, Canosa A, Cammarosano S, Ilardi A, Bertuzzo D, Bersano E, Cugnasco P, Grassano M, Pisano F, Mazzini L, Calvo A. Secular Trends of Amyotrophic Lateral Sclerosis: The Piemonte and Valle d'Aosta Register. JAMA Neurol 2017; 74:1097-1104. [PMID: 28692730 DOI: 10.1001/jamaneurol.2017.1387] [Citation(s) in RCA: 75] [Impact Index Per Article: 10.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/06/2023]
Abstract
Importance This study reports the long-term epidemiologic trends of amyotrophic lateral sclerosis (ALS) based on a prospective register. Objective To examine the 20-year epidemiologic trends of ALS in the Piemonte and Valle d'Aosta regions of Italy. Design, Setting, and Participants The Piemonte and Valle d'Aosta Register for ALS (PARALS) is an epidemiologic prospective register that covers 2 Italian regions (population of 4 476 931 inhabitants according to the 2011 census) from January 1, 1995, through December 31, 2014. Case ascertainment is based on multiple sources (neurologic departments, hospital discharge archives, and mortality records). Incidence rates are age and sex standardized for the Italian population of the 2011 census. Age-period-cohort (APC) analysis was performed using a Poisson regression model. Main Outcomes and Measures The primary study outcomes were long-term incidence and prevalence rates of ALS using a prospective design and their determinants. Results During the study period, a total of 2702 patients (mean [SD] age at onset, 65.7 [11.1] years; 1246 [46.1%] female and 1456 [53.9%] male) received a diagnosis of ALS between 1995 and 2014, corresponding to a crude annual incidence rate of 3.03 per 100 000 population (95% CI, 2.85-3.23) and an adjusted incidence rate of 2.78 per 100 000 population (95% CI, 2.57-2.96). The age-adjusted incidence rate increased in the 2 decades of the study (1995-2004: 2.66; 95% CI, 2.50-2.83; 2005-2014: 2.89; 95% CI, 2.71-3.07; P = .04), mostly in women. The adjusted rate ratio of men to women decreased from 1.27:1 (1995-2004) to 1.17:1 (2005-2014). The analysis of deviance for the APC regression models indicated that the drift variable is relevant in explaining the variation of ALS incidence rates over time in the overall population (change in deviance, 4.6553; P = .03) and in women (change in deviance, 3.8821; P = .05) but not in men (change in deviance, 0.77215; P = .38). A total of 479 patients with ALS were alive and had not undergone tracheostomy at the prevalence day (December 31, 2014), corresponding to a crude prevalence rate of 10.54 per 100 000 population (95% CI, 9.64-11.52). Conclusions and Relevance During the 1995 to 2014 period, the crude and adjusted incidences of ALS increased in Piemonte and Valle d'Aosta, mostly in women. The APC model revealed that the increase of ALS incidence is attributable to a birth cohort effect in women, with a peak in the 1930 cohort. The different increase of ALS incidence in men and women points to an effect of exogenous factors with a differential effect on the 2 sexes, acting on a genetic background.
Collapse
Affiliation(s)
- Adriano Chiò
- ALS Center, "Rita Levi Montalcini" Department of Neuroscience, University of Torino, Torino, Italy.,The Azienda Ospedaliero Universitaria Città della Salute e della Scienza di Torino, Torino, Italy.,The Neuroscience Institute of Torino, Torino, Italy
| | - Gabriele Mora
- ALS Center, "Salvatore Maugeri" Clinical-Scientific Institutes, Istituto di Ricovero e Cura a Carattere Scientifico, Milano, Italy
| | - Cristina Moglia
- ALS Center, "Rita Levi Montalcini" Department of Neuroscience, University of Torino, Torino, Italy.,The Azienda Ospedaliero Universitaria Città della Salute e della Scienza di Torino, Torino, Italy
| | - Umberto Manera
- ALS Center, "Rita Levi Montalcini" Department of Neuroscience, University of Torino, Torino, Italy
| | - Antonio Canosa
- ALS Center, "Rita Levi Montalcini" Department of Neuroscience, University of Torino, Torino, Italy
| | - Stefania Cammarosano
- ALS Center, "Rita Levi Montalcini" Department of Neuroscience, University of Torino, Torino, Italy
| | - Antonio Ilardi
- ALS Center, "Rita Levi Montalcini" Department of Neuroscience, University of Torino, Torino, Italy
| | - Davide Bertuzzo
- ALS Center, "Rita Levi Montalcini" Department of Neuroscience, University of Torino, Torino, Italy
| | - Enrica Bersano
- ALS Center, the Azienda Ospedaliero Universitaria Maggiore della Carità, Novara, Italy
| | - Paolo Cugnasco
- ALS Center, "Rita Levi Montalcini" Department of Neuroscience, University of Torino, Torino, Italy
| | - Maurizio Grassano
- ALS Center, "Rita Levi Montalcini" Department of Neuroscience, University of Torino, Torino, Italy
| | - Fabrizio Pisano
- Department of Neurological Rehabilitation, "Salvatore Maugeri" Clinical-Scientific Institute, Istituto di Ricovero e Cura a Carattere Scientifico, Veruno, Italy
| | - Letizia Mazzini
- ALS Center, the Azienda Ospedaliero Universitaria Maggiore della Carità, Novara, Italy
| | - Andrea Calvo
- ALS Center, "Rita Levi Montalcini" Department of Neuroscience, University of Torino, Torino, Italy.,The Azienda Ospedaliero Universitaria Città della Salute e della Scienza di Torino, Torino, Italy.,The Neuroscience Institute of Torino, Torino, Italy
| | | |
Collapse
|
4
|
Five-Year Incidence of Amyotrophic Lateral Sclerosis in British Columbia (2010-2015). Can J Neurol Sci 2016; 43:791-795. [PMID: 27476760 DOI: 10.1017/cjn.2016.280] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/12/2022]
Abstract
BACKGROUND Amyotrophic lateral sclerosis (ALS) is a fatal degenerative neurological disease with significant effects on quality of life. International studies continue to provide consistent incidence values, though complete case ascertainment remains a challenge. The Canadian population has been understudied, and there are currently no quantitative data on the incidence of ALS in British Columbia (BC). The objectives of this study were to determine the five-year incidence rates of ALS in BC and to characterize the demographic patterns of the disease. METHODS The capture-recapture method was employed to estimate ALS incidence over a five-year period (2010-2015). Two sources were used to identify ALS cases: one database from an ALS medical centre and another from a not-for-profit ALS organization. RESULTS During this time period, there were 690 incident cases within the two sources. The capture-recapture method estimated 57 unobserved cases, corresponding to a crude five-year incidence rate of 3.29 cases per 100,000 (CI 95%=3.05-3.53). The mean age of diagnosis was 64.6 (CI 95%=59.7-69.4), with 63.5 (CI 95%=56.9-70.1) for men and 65.7 (CI 95%=58.6-72.7) for women. There was a slight male preponderance in incidence, with a 1.05:1 ratio to females. Peak numbers in incidence occurred between the ages of 70 and 79. CONCLUSIONS The incidence of ALS in BC was found to be consistent with international findings though nominally higher than that in other Canadian provinces to date.
Collapse
|
5
|
Lasry O, Dudley RW, Fuhrer R, Torrie J, Carlin R, Marcoux J. Traumatic brain injury in a rural indigenous population in Canada: a community-based approach to surveillance. CMAJ Open 2016; 4:E249-59. [PMID: 27398371 PMCID: PMC4933602 DOI: 10.9778/cmajo.20150105] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/13/2022] Open
Abstract
BACKGROUND Indigenous populations are disproportionately affected by traumatic brain injury. These populations rely on large jurisdiction surveillance efforts to inform their prevention strategies, which may not address their needs. We examined the incidence and determinants of traumatic brain injury in an indigenous population in the Terres-Cries-de-la-Baie-James health region of the province of Quebec and compared them with the incidence and determinants in 2 neighbouring health regions and in the province overall. METHODS We conducted a retrospective population-based cohort study of patients in Quebec admitted to hospital with incident traumatic brain injury, stratified by health region (Terres-Cries-de-la-Baie-James, Nunavik and Nord-du-Québec), from 2000 to 2012. We used MED-ÉCHO administrative data for case-finding. A subgroup analysis of adults in the Terres-Cries-de-la-Baie-James health region was completed to assess determinants of the severity of traumatic brain injury and patient outcomes. RESULTS A total of 172 hospital admissions for incident traumatic brain injury occurred in the Terres-Cries-de-la-Baie-James region during the study period. The incidence was 92.1 per 100 000 person-years, and the adjusted incidence rate ratio was 1.84 (95% confidence interval 1.56-2.17) compared with the entire province. The incidence was higher than in the neighbouring nonindigenous population (Nord-du-Québec) but significantly lower than in the neighbouring indigenous population (Nunavik). Determinants of traumatic brain injury in the Terres-Cries-de-la-Baie-James region differed from those in the neighbouring populations and in the entire province. INTERPRETATION We found that the incidence rates and determinants of traumatic brain injury requiring hospital admission varied greatly between the three regions studied. Community-based surveillance efforts should be encouraged to inform the development of relevant prevention strategies.
Collapse
Affiliation(s)
- Oliver Lasry
- Department of Epidemiology, Biostatistics and Occupational Health (Lasry, Fuhrer), McGill University, Montréal, Que.; Department of Neurosurgery (Lasry, Marcoux), McGill University Health Centre - Montréal General Hospital, Montréal, Qué.; Department of Surgery (Dudley), Division of Neurosurgery, McGill University Health Centre - Montréal Children's Hospital, Montréal, Qué.; Department of Public Health (Torrie), Cree Board of Health and Social Services of James Bay, Mistissini, Qué.; Department of Public Health (Carlin), Cree Board of Health and Social Services of James Bay, Montréal, Qué
| | - Roy W Dudley
- Department of Epidemiology, Biostatistics and Occupational Health (Lasry, Fuhrer), McGill University, Montréal, Que.; Department of Neurosurgery (Lasry, Marcoux), McGill University Health Centre - Montréal General Hospital, Montréal, Qué.; Department of Surgery (Dudley), Division of Neurosurgery, McGill University Health Centre - Montréal Children's Hospital, Montréal, Qué.; Department of Public Health (Torrie), Cree Board of Health and Social Services of James Bay, Mistissini, Qué.; Department of Public Health (Carlin), Cree Board of Health and Social Services of James Bay, Montréal, Qué
| | - Rebecca Fuhrer
- Department of Epidemiology, Biostatistics and Occupational Health (Lasry, Fuhrer), McGill University, Montréal, Que.; Department of Neurosurgery (Lasry, Marcoux), McGill University Health Centre - Montréal General Hospital, Montréal, Qué.; Department of Surgery (Dudley), Division of Neurosurgery, McGill University Health Centre - Montréal Children's Hospital, Montréal, Qué.; Department of Public Health (Torrie), Cree Board of Health and Social Services of James Bay, Mistissini, Qué.; Department of Public Health (Carlin), Cree Board of Health and Social Services of James Bay, Montréal, Qué
| | - Jill Torrie
- Department of Epidemiology, Biostatistics and Occupational Health (Lasry, Fuhrer), McGill University, Montréal, Que.; Department of Neurosurgery (Lasry, Marcoux), McGill University Health Centre - Montréal General Hospital, Montréal, Qué.; Department of Surgery (Dudley), Division of Neurosurgery, McGill University Health Centre - Montréal Children's Hospital, Montréal, Qué.; Department of Public Health (Torrie), Cree Board of Health and Social Services of James Bay, Mistissini, Qué.; Department of Public Health (Carlin), Cree Board of Health and Social Services of James Bay, Montréal, Qué
| | - Robert Carlin
- Department of Epidemiology, Biostatistics and Occupational Health (Lasry, Fuhrer), McGill University, Montréal, Que.; Department of Neurosurgery (Lasry, Marcoux), McGill University Health Centre - Montréal General Hospital, Montréal, Qué.; Department of Surgery (Dudley), Division of Neurosurgery, McGill University Health Centre - Montréal Children's Hospital, Montréal, Qué.; Department of Public Health (Torrie), Cree Board of Health and Social Services of James Bay, Mistissini, Qué.; Department of Public Health (Carlin), Cree Board of Health and Social Services of James Bay, Montréal, Qué
| | - Judith Marcoux
- Department of Epidemiology, Biostatistics and Occupational Health (Lasry, Fuhrer), McGill University, Montréal, Que.; Department of Neurosurgery (Lasry, Marcoux), McGill University Health Centre - Montréal General Hospital, Montréal, Qué.; Department of Surgery (Dudley), Division of Neurosurgery, McGill University Health Centre - Montréal Children's Hospital, Montréal, Qué.; Department of Public Health (Torrie), Cree Board of Health and Social Services of James Bay, Mistissini, Qué.; Department of Public Health (Carlin), Cree Board of Health and Social Services of James Bay, Montréal, Qué
| |
Collapse
|
6
|
|